137 related articles for article (PubMed ID: 24450579)
41. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M
BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887
[TBL] [Abstract][Full Text] [Related]
42. Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms.
Goel S; Paoli C; Iurlo A; Pereira A; Efficace F; Barbui T; Tefferi A; Vannucchi AM; Cervantes F
Eur J Haematol; 2017 Jul; 99(1):36-41. PubMed ID: 28370510
[TBL] [Abstract][Full Text] [Related]
43. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases.
Fuldeore M; Yang H; Du EX; Soliman AM; Wu EQ; Winkel C
Fertil Steril; 2015 Jan; 103(1):163-71. PubMed ID: 25455535
[TBL] [Abstract][Full Text] [Related]
44. Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group.
Rotunno G; Pacilli A; Artusi V; Rumi E; Maffioli M; Delaini F; Brogi G; Fanelli T; Pancrazzi A; Pietra D; Bernardis I; Belotti C; Pieri L; Sant'Antonio E; Salmoiraghi S; Cilloni D; Rambaldi A; Passamonti F; Barbui T; Manfredini R; Cazzola M; Tagliafico E; Vannucchi AM; Guglielmelli P
Am J Hematol; 2016 Jul; 91(7):681-6. PubMed ID: 27037840
[TBL] [Abstract][Full Text] [Related]
45. Complications and conversions in myeloproliferative disorders: an analysis of 356 cases.
Wang Y; Zuo A; Liu Y; Liu B; Hao C; Wang L; Zhou X; Qian L
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):314-7. PubMed ID: 12411064
[TBL] [Abstract][Full Text] [Related]
46. Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.
Kaifie A; Isfort S; Gattermann N; Hollburg W; Klausmann M; Wolf D; Maintz C; Hänel M; Goekkurt E; Göthert JR; Platzbecker U; Geer T; Parmentier S; Jost E; Serve H; Ehninger G; Berdel WE; Brümmendorf TH; Koschmieder S;
Ann Hematol; 2016 Sep; 95(9):1399-410. PubMed ID: 27334946
[TBL] [Abstract][Full Text] [Related]
47. Direct and indirect costs for patients with myeloproliferative neoplasms.
Yu J; Nelson J; Marlin T; Braunstein E; Jerry M
Leuk Lymphoma; 2024 Apr; ():1-8. PubMed ID: 38676959
[TBL] [Abstract][Full Text] [Related]
48. Mild traumatic brain injury in the United States: demographics, brain imaging procedures, health-care utilization and costs.
Pavlov V; Thompson-Leduc P; Zimmer L; Wen J; Shea J; Beyhaghi H; Toback S; Kirson N; Miller M
Brain Inj; 2019; 33(9):1151-1157. PubMed ID: 31241427
[No Abstract] [Full Text] [Related]
49. Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population.
Lee S; Xie L; Wang Y; Vaidya N; Baser O
J Med Econ; 2018 Jun; 21(6):564-570. PubMed ID: 29359606
[TBL] [Abstract][Full Text] [Related]
50. Real-world health plan claims analysis of differences in healthcare utilization and total cost in patients suffering from cluster headaches and those without headache-related conditions.
Polson M; Lord TC; Evangelatos TM; Lopes M; Santaniello BL
Am J Manag Care; 2017 Nov; 23(16 Suppl):S295-S299. PubMed ID: 29144719
[TBL] [Abstract][Full Text] [Related]
51. Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.
Brabrand M; Hansen KN; Laursen CB; Larsen TS; Vestergaard H; Abildgaard N
Eur J Haematol; 2019 Mar; 102(3):227-234. PubMed ID: 30450659
[TBL] [Abstract][Full Text] [Related]
52. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
53. Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone.
Ben-Joseph R; Bell JA; Chitnis A; Kansal A; Holly P; Paramore C; Wild H
J Med Econ; 2016; 19(2):169-80. PubMed ID: 26451633
[TBL] [Abstract][Full Text] [Related]
54. Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a U.S. health plan.
Armstrong AW; Zhao Y; Herrera V; Li Y; Bancroft T; Hull M; Altan A
J Dermatolog Treat; 2017 Nov; 28(7):613-622. PubMed ID: 28320213
[TBL] [Abstract][Full Text] [Related]
55. Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: clinical correlates and prognostic studies.
Pardanani A; Drake MT; Finke C; Lasho TL; Rozell SA; Jimma T; Tefferi A
Am J Hematol; 2011 Dec; 86(12):1013-6. PubMed ID: 22086864
[TBL] [Abstract][Full Text] [Related]
56. Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review.
Chen K; Krasner A; Li N; Xiang CQ; Totev T; Xie J
J Med Econ; 2019 Nov; 22(11):1141-1152. PubMed ID: 31124721
[No Abstract] [Full Text] [Related]
57. Dkk3 levels in patients with myeloproliferative neoplasms.
Medinger M; Muesser P; Girsberger S; Skoda R; Tzankov A; Buser A; Passweg J; Tsakiris DΑ
Thromb Res; 2014 Feb; 133(2):218-21. PubMed ID: 24309205
[TBL] [Abstract][Full Text] [Related]
58. Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study.
Shrestha R; Giri S; Armitage JO; Bhatt VR
Future Oncol; 2017 Jun; 13(14):1239-1246. PubMed ID: 28589759
[TBL] [Abstract][Full Text] [Related]
59. Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.
Insinga RP; Itzler RF; Pellissier JM
Pharmacoeconomics; 2007; 25(2):155-69. PubMed ID: 17249857
[TBL] [Abstract][Full Text] [Related]
60. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
